BridgeMD
New treatment option for Postoperative Nausea and Vomiting
Official title Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07190495
What this study is testing
What is Ginger?
Ginger is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for postoperative nausea and vomiting.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years.
- Scheduled for elective laparoscopic cholecystectomy under general anesthesia.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Able to understand the study procedures and provide written informed consent.
You likely can't join if
- Known allergy or hypersensitivity to ginger
- Documented history of bleeding disorders or current treatment with anticoagulant agents
- History of severe postoperative nausea and vomiting or an Apfel score of 4
- Administration of antiemetic drugs or corticosteroids during the preoperative period
- Pregnancy or breastfeeding
- Active gastrointestinal or liver disease
The study team makes the final eligibility decision.
Where it's taking place
- Nabeul, Nabeul Governorate, Tunisia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nabeul, Nabeul Governorate, Tunisia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.